Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Performing Resi Mortgage Portfolio

12 Dec 2014 16:31

RNS Number : 6965Z
Bank of Ireland(Governor&Co)
12 December 2014
 



The Governor and Company of the Bank of Ireland ('Bank of Ireland' or the 'Group')

 

Acquisition of Performing Residential Mortgage Portfolio

 

12 December 2014

 

Bank of Ireland has today agreed terms to acquire a portfolio of performing residential mortgages from Kieran Wallace and Eamonn Richardson, the Special Liquidators to Irish Bank Resolution Corporation Ltd (in Special Liquidation) ("IBRC"). Consideration of €253m is payable in cash on completion. The acquisition is consistent with the Bank's plan to grow its lending volumes. The transaction is expected to close shortly.

 

Mr Gavin Kelly, Director, Bank of Ireland Consumer Banking commented: "We are pleased to announce this transaction which is a positive development for our business and look forward to welcoming a new group of customers to Bank of Ireland."

 

 

Ends.

 

For further information please contact:

 

Bank of Ireland

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Mark Spain Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

 

 

Note:

Bank of Ireland and IBRC have a common shareholder in the form of the Irish State and for the purposes of the Financial Conduct Authority Listing Rules, Bank of Ireland is a related party to the Irish State. This announcement is being made, inter alia, to satisfy the notification requirements of the Financial Conduct Authority Listing Rules pertaining to smaller related party transactions (LR 11.1.10 R) and the Irish Stock Exchange Listing Rules pertaining to Class 3 transactions (LR 7.3.2).

 

 Forward Looking Statement

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the 'Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal,' 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, level of ownership by the Irish Government, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, future payment of dividends, the implementation of changes in respect of certain of the Group's pension schemes, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following: geopolitical risks, such as those associated with crises in the Middle East and increasing political tensions in respect of the Ukraine, which could potentially adversely impact the markets in which the Group operates; concerns on sovereign debt and financial uncertainties in the EU and in member countries and the potential effects of those uncertainties on the Group; general and sector specific economic conditions in Ireland, the United Kingdom and the other markets in which the Group operates; the ability of the Group to generate additional liquidity and capital as required; any further capital or other assessments undertaken by regulators; property market conditions in Ireland and the United Kingdom; the potential exposure of the Group to various types of market risks, such as interest rate risk, foreign exchange rate risk, credit risk and commodity price risk; deterioration in the credit quality of the Group's borrowers and counterparties, as well as increased difficulties in relation to the recoverability of loans and other amounts due from such borrowers and counterparties, have resulted in significant increases, and could result in further significant increases, in the Group's impaired loans and impairment provisions; implications of the Personal Insolvency Act 2012 and measures introduced by the Central Bank of Ireland to address mortgage arrears on the Group's distressed debt recovery and impairment provisions; The impact on lending and other activity arising from the emerging macro prudential policies; the performance and volatility of international capital markets; the effects of the Irish Government's stockholding in the Group (through the NPRFC) and possible changes in the level of such stockholding; the impact of downgrades in the Group's or the Irish Government's credit ratings or outlook; the stability of the Eurozone; changes in the Irish and United Kingdom banking systems; changes in applicable laws, regulations and taxes in jurisdictions in which the Group operates particularly banking regulation by the Irish and United Kingdom Governments together with implementation of the Single Supervisory Mechanism and establishment of the Single Resolution Mechanism and the conduct and outcomes of asset quality reviews and stress tests; the exercise by regulators of powers of regulation and oversight in Ireland and the United Kingdom; the introduction of new government policies or the amendment of existing policies in Ireland or the United Kingdom; the outcome of any legal claims brought against the Group by third parties or legal or regulatory proceedings or any Irish banking inquiry more generally, that may have implications for the Group; the development and implementation of the Group's strategy, including the implications of the continuing obligations components of the Group's revised EU Commission restructuring plan and the Group's ability to achieve net interest margin increases and cost reductions; the responsibility of the Group for contributing to compensation schemes in respect of banks and other authorised financial services firms in Ireland, the United Kingdom and the Isle of Man that may be unable to meet their obligations to customers; the inherent risk within the Group's life assurance business involving claims, as well as market conditions generally; potential further contributions to the Group sponsored pension schemes if the value of pension fund assets is not sufficient to cover potential obligations; the exposure of the Group to NAMA losses in the event that NAMA has an underlying loss at the conclusion of its operations, which could adversely impact the Group's capital and results of operations; the impact of the continuing implementation of significant regulatory developments such as Basel III, Capital Requirements Directive (CRD) IV, Solvency II and the Recovery and Resolution Directive; and the Group's ability to address weaknesses or failures in its internal processes and procedures including information technology issues and equipment failures and other operational risks.

 

Nothing in this document should be considered to be a forecast of future profitability or financial position and none of the information in this document is or is intended to be a profit forecast or profit estimate. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKAAFANLFFF
Date   Source Headline
19th Dec 20119:55 amRNSSale of Burdale and Deleveraging Update
8th Dec 20115:00 pmRNSEBA Capital Exercise
2nd Dec 201110:12 amRNSSubordinated Liabilities Order
2nd Dec 20117:23 amRNSTender Offers - Results Announcement
2nd Dec 20117:06 amRNSTender Offer Results
28th Nov 20117:02 amRNSDeleveraging Plan Update
23rd Nov 20117:00 amRNSSubordinated Liabilities Order
21st Nov 20113:52 pmRNSTender Offer - (Replacement)
21st Nov 20112:13 pmRNSTender Offer
21st Nov 20112:12 pmRNSTender Offer
11th Nov 201111:05 amRNSInterim Management Statement
3rd Nov 20113:50 pmRNSRepurchase
19th Oct 20114:50 pmRNSForm TR1
19th Oct 20114:50 pmRNSForm TR1
19th Oct 20114:50 pmRNSForm TR1
19th Oct 20114:49 pmRNSForm TR1
19th Oct 20114:49 pmRNSForm TR1- NPRFC
17th Oct 20113:08 pmRNSCompletion of Investment in Bank of Ireland
14th Oct 20116:19 pmRNSDeleveraging Plan Update
6th Oct 20112:57 pmRNSRepurchase
23rd Sep 20112:47 pmRNSTender Offer - Results Announcement
16th Sep 20114:35 pmRNSPrice Monitoring Extension
13th Sep 201111:21 amRNSRepurchase
9th Sep 201111:52 amRNSResult of EGM
31st Aug 20115:13 pmRNSTotal Voting Rights
31st Aug 201111:36 amRNSNotice of Results of Meeting
26th Aug 20115:06 pmRNSRepurchase
26th Aug 20114:44 pmRNSRepurchase
24th Aug 20114:52 pmRNSRule 9 Waiver Approval and Notice of EGC
24th Aug 201111:31 amRNSCommencement of Tender Offer
19th Aug 201111:26 amRNSRepurchase
18th Aug 20119:55 amRNSForm TR1
17th Aug 201110:05 amRNSForm TR 1
16th Aug 20116:11 pmRNSForm TR1
15th Aug 201111:49 amRNSTotal Voting Rights
15th Aug 20117:00 amRNSMain Securities Market Notice
10th Aug 20116:22 pmRNSConversion of Allotment Instruments
10th Aug 20116:22 pmRNSDelayed Settlement Security Results
10th Aug 201111:58 amRNSForm TR1
10th Aug 20117:00 amRNSHalf Yearly Report
9th Aug 20113:47 pmRNSDelayed Settlement Security Results
3rd Aug 20116:15 pmRNSForm TR1
3rd Aug 20116:00 pmRNSForm TR1
3rd Aug 20115:45 pmRNSForm TR1
3rd Aug 20113:04 pmRNSDirector/PDMR Shareholding
2nd Aug 20114:09 pmRNSUpdate on EU Restructuring and Viability Plan
2nd Aug 201112:57 pmRNSRepurchase
1st Aug 201112:18 pmRNSRepurchase
29th Jul 20113:55 pmRNSTotal Voting Rights
29th Jul 20112:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.